Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cytel Inc. has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving expansion of the advanced analytics capabilities available to clinicians looking to streamline therapeutic development.
read more
Wednesday, March 23, 2022
Shenandoah Biotechnology is a privately held company located in Warminster, Pennsylvania, that manufactures recombinant proteins including cytokines and growth factors. Shenandoah Biotechnology recently launched their CTG Grade™ line of cytokines and...
read more
Wednesday, March 23, 2022
Exothera S.A. received Good Manufacturing Practices (GMP) certification from the Federal Agency for Medicines and Health Products (FAMHP) for its facilities in Jumet, Belgium. This accreditation follows a series of successful inspections ensuring ...
read more
Wednesday, March 23, 2022
Kayentis has announced the launch of a fully integrated patient-centric platform that optimizes the management of hybrid and Decentralized Clinical Trials (DCT).
read more
DFE Pharma (excipients solution provider), Harro Höfliger (equipment supplier), and Sterling (API manufacturer) - announced a unique partnership with the establishment of “Inhalation Together” (INTO) in the field of dry powder inhalation (DPI).
read more
Sobi® announced that its contract with Pfizer for the manufacture of drug substance for ReFacto AF®/Xyntha® (ReFacto) has been amended due to clarity of final order volumes and will now expire in the first quarter of 2024, earlier than the previous ...
read more
Heat Biologics, Inc. has unveiled enhanced allogeneic cell therapy manufacturing capabilities through its Scorpion Biological Services subsidiary.
read more
ScienceMedia announced their partnership with Apex Mobile Clinical Research (AMCR), a provider of decentralized clinical trial solutions and services to underserved communities. AMCR will be using ScienceMedia's protocol compliance management ...
read more
Rentschler Biopharma and Vetter announced that the companies are unveiling Xpert Alliance, a joint visualization of their strategic collaboration.
read more
Wednesday, March 30, 2022
Alcami announced plans to expand its biostorage footprint at Masy BioServices. Joining the company's existing New England campus is a new 160,000 square-foot facility, purpose-built for cGMP pallet storage space at 15°C to 30°C.
read more
Wednesday, March 30, 2022
CVS Health has entered into an agreement with the State of Florida to resolve claims dating back more than a decade related to prescriptions for opioid medications that were filled at Florida CVS Pharmacy locations.
read more
Lonza announced its membership in the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS). Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation...
read more
Silo Pharma, Inc. has entered into an agreement with Frontage Laboratories, a CRO (contract research organization), providing integrated, science-driven, product development services throughout the drug discovery and development process that enable ...
read more
Medidata, a Dassault Systèmes company, announced that Labcorp has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of...
read more
Cryoport, Inc. announced that its New Prague facility has returned to full production. As previously announced, a fire occurred in a portion of the MVE Biological Solutions manufacturing facility located in New Prague, Minnesota on January 25, 2022, ...
read more